- Home
- QTRX vs PLX Comparison
QTRX vs PLX Comparison
Compare QTRX & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QTRX | PLX |
|---|---|---|
| Founded | 2007 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 159.5M |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QTRX | PLX |
|---|---|---|
| Price | $2.61 | $2.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 844.7K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $37,632,000.00 | ★ $52,744,000.00 |
| Revenue This Year | $25.49 | $36.81 |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | ★ 64.52 | N/A |
| 52 Week Low | $2.40 | $1.34 |
| 52 Week High | $8.77 | $3.19 |
Technical Indicators
Market Signals| Indicator | QTRX | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 35.48 | 55.66 |
| Support Level | $2.40 | $2.06 |
| Resistance Level | $3.74 | $2.16 |
| Average True Range (ATR) | 0.27 | 0.11 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 23.76 | 91.38 |
Price Performance
Historical ComparisonAbout QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.